Peringatan Keamanan

Intravenous LD50 in rat is 51 mg/kg.

Thiamylal

DB01154

small molecule approved vet_approved

Deskripsi

A barbiturate that is administered intravenously for the production of complete anesthesia of short duration, for the induction of general anesthesia, or for inducing a hypnotic state. (From Martindale, The Extra Pharmacopoeia, 30th ed, p919)

Struktur Molekul 2D

Berat 254.349
Wujud solid

Peta Jejaring Molekuler
Legenda: ObatTargetGenEnzim(Panah → menunjukkan arah efek / relasi)TransporterCarrier

Profil Farmakokinetik

Waktu Paruh (Half-Life) Although no studies have been performed on humans, the half-life in cats is 14.3 hours.
Volume Distribusi -
Klirens (Clearance) -

Absorpsi

Rapidly absorbed (high lipid solubility).

Metabolisme

Hepatic.

Rute Eliminasi

Data eliminasi belum tersedia.

Interaksi Obat

1367 Data
Buprenorphine Thiamylal may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.
Doxylamine Doxylamine may increase the central nervous system depressant (CNS depressant) activities of Thiamylal.
Dronabinol Dronabinol may increase the central nervous system depressant (CNS depressant) activities of Thiamylal.
Droperidol Droperidol may increase the central nervous system depressant (CNS depressant) activities of Thiamylal.
Hydrocodone Thiamylal may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.
Hydroxyzine Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Thiamylal.
Magnesium sulfate The therapeutic efficacy of Thiamylal can be increased when used in combination with Magnesium sulfate.
Methotrimeprazine Thiamylal may increase the central nervous system depressant (CNS depressant) activities of Methotrimeprazine.
Metyrosine Thiamylal may increase the sedative activities of Metyrosine.
Minocycline Minocycline may increase the central nervous system depressant (CNS depressant) activities of Thiamylal.
Mirtazapine Thiamylal may increase the central nervous system depressant (CNS depressant) activities of Mirtazapine.
Nabilone Nabilone may increase the central nervous system depressant (CNS depressant) activities of Thiamylal.
Orphenadrine Thiamylal may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.
Paraldehyde Thiamylal may increase the central nervous system depressant (CNS depressant) activities of Paraldehyde.
Perampanel Perampanel may increase the central nervous system depressant (CNS depressant) activities of Thiamylal.
Pramipexole Thiamylal may increase the sedative activities of Pramipexole.
Ropinirole Thiamylal may increase the sedative activities of Ropinirole.
Rotigotine Thiamylal may increase the sedative activities of Rotigotine.
Rufinamide The risk or severity of adverse effects can be increased when Rufinamide is combined with Thiamylal.
Suvorexant Thiamylal may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.
Tapentadol Tapentadol may increase the central nervous system depressant (CNS depressant) activities of Thiamylal.
Thalidomide Thiamylal may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
Zolpidem Thiamylal may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.
Mefloquine The therapeutic efficacy of Thiamylal can be decreased when used in combination with Mefloquine.
Orlistat Orlistat can cause a decrease in the absorption of Thiamylal resulting in a reduced serum concentration and potentially a decrease in efficacy.
Acetaminophen The metabolism of Acetaminophen can be increased when combined with Thiamylal.
Propacetamol The metabolism of Propacetamol can be increased when combined with Thiamylal.
Chloramphenicol The metabolism of Thiamylal can be decreased when combined with Chloramphenicol.
Doxycycline The serum concentration of Doxycycline can be decreased when it is combined with Thiamylal.
Felbamate The serum concentration of Thiamylal can be increased when it is combined with Felbamate.
Griseofulvin The serum concentration of Griseofulvin can be decreased when it is combined with Thiamylal.
Lamotrigine The serum concentration of Lamotrigine can be decreased when it is combined with Thiamylal.
Mianserin The therapeutic efficacy of Thiamylal can be decreased when used in combination with Mianserin.
Methylphenobarbital The risk or severity of adverse effects can be increased when Methylphenobarbital is combined with Thiamylal.
Pyridoxine The metabolism of Thiamylal can be increased when combined with Pyridoxine.
Teniposide The serum concentration of Teniposide can be decreased when it is combined with Thiamylal.
Ulipristal The serum concentration of Ulipristal can be decreased when it is combined with Thiamylal.
Voriconazole The serum concentration of Voriconazole can be decreased when it is combined with Thiamylal.
Topotecan Thiamylal may increase the excretion rate of Topotecan which could result in a lower serum level and potentially a reduction in efficacy.
Methadone The risk or severity of adverse effects can be increased when Methadone is combined with Thiamylal.
Sodium oxybate Thiamylal may increase the central nervous system depressant (CNS depressant) activities of Sodium oxybate.
Tetracosactide The risk or severity of liver damage can be increased when Tetracosactide is combined with Thiamylal.
Aminophylline The therapeutic efficacy of Thiamylal can be decreased when used in combination with Aminophylline.
Meperidine Thiamylal may increase the hypotensive and central nervous system depressant (CNS depressant) activities of Meperidine.
Somatostatin The risk or severity of adverse effects can be increased when Somatostatin is combined with Thiamylal.
Ethanol Thiamylal may increase the central nervous system depressant (CNS depressant) activities of Ethanol.
Azelastine Thiamylal may increase the central nervous system depressant (CNS depressant) activities of Azelastine.
Brimonidine Brimonidine may increase the central nervous system depressant (CNS depressant) activities of Thiamylal.
Fluvoxamine The risk or severity of adverse effects can be increased when Thiamylal is combined with Fluvoxamine.
Citalopram The risk or severity of adverse effects can be increased when Thiamylal is combined with Citalopram.
Duloxetine The risk or severity of adverse effects can be increased when Thiamylal is combined with Duloxetine.
Trazodone The risk or severity of adverse effects can be increased when Thiamylal is combined with Trazodone.
Paroxetine The risk or severity of adverse effects can be increased when Thiamylal is combined with Paroxetine.
Sertraline The risk or severity of adverse effects can be increased when Thiamylal is combined with Sertraline.
Sibutramine The risk or severity of adverse effects can be increased when Thiamylal is combined with Sibutramine.
Escitalopram The risk or severity of adverse effects can be increased when Thiamylal is combined with Escitalopram.
Zimelidine The risk or severity of adverse effects can be increased when Thiamylal is combined with Zimelidine.
Dapoxetine The risk or severity of adverse effects can be increased when Thiamylal is combined with Dapoxetine.
Desvenlafaxine The risk or severity of adverse effects can be increased when Thiamylal is combined with Desvenlafaxine.
Seproxetine The risk or severity of adverse effects can be increased when Thiamylal is combined with Seproxetine.
Indalpine The risk or severity of adverse effects can be increased when Thiamylal is combined with Indalpine.
Ritanserin The risk or severity of adverse effects can be increased when Thiamylal is combined with Ritanserin.
Alaproclate The risk or severity of adverse effects can be increased when Thiamylal is combined with Alaproclate.
Milnacipran The risk or severity of adverse effects can be increased when Thiamylal is combined with Milnacipran.
Cyclosporine The metabolism of Cyclosporine can be increased when combined with Thiamylal.
Methyclothiazide The risk or severity of hypotension and orthostatic hypotension can be increased when Thiamylal is combined with Methyclothiazide.
Chlorthalidone The risk or severity of hypotension and orthostatic hypotension can be increased when Thiamylal is combined with Chlorthalidone.
Bendroflumethiazide The risk or severity of hypotension and orthostatic hypotension can be increased when Thiamylal is combined with Bendroflumethiazide.
Metolazone The risk or severity of hypotension and orthostatic hypotension can be increased when Thiamylal is combined with Metolazone.
Benzthiazide The risk or severity of hypotension and orthostatic hypotension can be increased when Thiamylal is combined with Benzthiazide.
Hydroflumethiazide The risk or severity of hypotension and orthostatic hypotension can be increased when Thiamylal is combined with Hydroflumethiazide.
Indapamide The risk or severity of hypotension and orthostatic hypotension can be increased when Thiamylal is combined with Indapamide.
Chlorothiazide The risk or severity of hypotension and orthostatic hypotension can be increased when Thiamylal is combined with Chlorothiazide.
Hydrochlorothiazide The risk or severity of hypotension and orthostatic hypotension can be increased when Thiamylal is combined with Hydrochlorothiazide.
Trichlormethiazide The risk or severity of hypotension and orthostatic hypotension can be increased when Thiamylal is combined with Trichlormethiazide.
Polythiazide The risk or severity of hypotension and orthostatic hypotension can be increased when Thiamylal is combined with Polythiazide.
Quinethazone The risk or severity of hypotension and orthostatic hypotension can be increased when Thiamylal is combined with Quinethazone.
Cyclopenthiazide The risk or severity of hypotension and orthostatic hypotension can be increased when Thiamylal is combined with Cyclopenthiazide.
Epitizide The risk or severity of hypotension and orthostatic hypotension can be increased when Thiamylal is combined with Epitizide.
Protriptyline The metabolism of Protriptyline can be increased when combined with Thiamylal.
Amoxapine The metabolism of Amoxapine can be increased when combined with Thiamylal.
Desipramine The metabolism of Desipramine can be increased when combined with Thiamylal.
Amineptine The metabolism of Amineptine can be increased when combined with Thiamylal.
Dimetacrine The metabolism of Dimetacrine can be increased when combined with Thiamylal.
Butriptyline The metabolism of Butriptyline can be increased when combined with Thiamylal.
Dosulepin The metabolism of Dosulepin can be increased when combined with Thiamylal.
Oxaprotiline The metabolism of Oxaprotiline can be increased when combined with Thiamylal.
Opipramol The metabolism of Opipramol can be increased when combined with Thiamylal.
Amitriptylinoxide The metabolism of Amitriptylinoxide can be increased when combined with Thiamylal.
Dibenzepin The metabolism of Dibenzepin can be increased when combined with Thiamylal.
Quinupramine The metabolism of Quinupramine can be increased when combined with Thiamylal.
Melitracen The metabolism of Melitracen can be increased when combined with Thiamylal.
Lofepramine The metabolism of Lofepramine can be increased when combined with Thiamylal.
Iprindole The metabolism of Iprindole can be increased when combined with Thiamylal.
Imipramine oxide The metabolism of Imipramine oxide can be increased when combined with Thiamylal.
Phenindione The metabolism of Phenindione can be increased when combined with Thiamylal.
Coumarin The metabolism of Coumarin can be increased when combined with Thiamylal.
Tioclomarol The metabolism of Tioclomarol can be increased when combined with Thiamylal.
(R)-warfarin The metabolism of (R)-warfarin can be increased when combined with Thiamylal.
(S)-Warfarin The metabolism of (S)-Warfarin can be increased when combined with Thiamylal.

Target Protein

Gamma-aminobutyric acid receptor subunit gamma-3 GABRG3
ATP-sensitive inward rectifier potassium channel 8 KCNJ8
ATP-sensitive inward rectifier potassium channel 11 KCNJ11
Gamma-aminobutyric acid receptor subunit alpha-1 GABRA1

Referensi & Sumber

Belum ada data referensi/link/attachment untuk obat ini pada database. Jalankan import DrugBank untuk mengisi field referensi.

Contoh Produk & Brand

Produk: 0 • International brands: 2
International Brands
  • Surital
  • Thioseconal

Sekuens Gen/Protein (FASTA)

Sekuens dimuat saat dibutuhkan agar halaman tetap ringan.
© 2025 Digital Pharmacy Research - Universitas Esa Unggul